ATAaron J. Trask

Aaron J. Trask

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron J. Trask has a total of 151 co-authors. Here are the top co-authors by number of shared publications:

  • Patricia E. McCallinhart

    Center for Cardiovascular Research and The Heart Center, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, USA

    12 shared publications
  • Pamela A. Lucchesi

    Department of Undergraduate Medical Education, University of Texas Tyler School of Medicine, Tyler, USA

    7 shared publications
  • Ian L. Sunyecz

    Center for Cardiovascular Research and The Heart Center, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, USA

    3 shared publications
  • Brant Edward Isakson

    University of Virginia School of Medicine

    2 shared publications
  • Brenda Lilly

    Center for Cardiovascular Research, The Heart Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States

    2 shared publications
  • Cameron G. McCarthy

    University of South Carolina

    2 shared publications

Latest Publications

  • Open Access

    CORAL: a machine learning algorithm to identify coronary microvascular disease from doppler coronary blood flow patterns

    by Aaron J. Trask, Yukie Ueyama, Jamie Bossenbroek, Michael R. McDermott, Patricia E. McCallinhart, Arslan Erdengasileng, Ian L. Sunyecz, William C. Ray, Christopher W. Bartlett

  • Guidelines for evaluating endothelial function in vascular tissue

    by Cameron G. McCarthy, Christian Aalkjær, Pooneh Bagher, Andreas M. Beyer, Ebbe Boedtkjer, Gisele F. Bomfim, Jerome W. Breslin, Ana M. Briones, Jorge A. Castorena-Gonzalez, Tiago J. Costa, et al.

    The endothelium plays a central role in maintaining vascular homeostasis by orchestrating vascular tone, inflammation, healing, permeability, and thrombosis. Assessing endothelial function in vascular tissue is essential for understanding the cellular and molecular mechanisms underlying cardiovascular physiology and pathology. Traditional approaches, such as wire and pressure myography, have been instrumental in defining endothelium-dependent responses and identifying key pharmacological targets. However, the complexity and heterogeneity of endothelial cells across vascular beds and their dynamic phenotypic changes in health and disease necessitate the incorporation of new investigative strategies. Emerging methodologies, including bulk and single-cell transcriptomics, proteomics, and advanced imaging, now provide unprecedented insights into endothelial cell diversity and function. A team of leading experts in the field, who collectively reached a consensus on the most widely used techniques to evaluate endothelial function, developed these guidelines. The document establishes best practices for assessing endothelial function, from endothelial cell cultures to isolated vascular tissues, integrating conventional functional assays with modern molecular approaches. By fostering methodological consistency and embracing innovation, our goal is to enhance rigor, reproducibility, understanding, and discovery in endothelial biology.


  • Open Access

    Single cell and spatial transcriptomic profiling of the type 2 diabetic coronary microcirculation and myocardium

    by Patricia E. McCallinhart, Corinne H. Strawser, Elizabeth A. R. Garfinkle, Jaye B. Navarro, Cynthia McAllister, Tatyana A. Vetter, Pamela A. Lucchesi, Elaine R. Mardis, Louisa Mezache, Rengasayee Veeraraghavan, et al.

    Coronary microvascular disease (CMD) is an early complication of type 2 diabetes (T2D) involving adverse endothelial and smooth muscle function, vascular remodeling, and alterations in mechanics. These culminate in impaired coronary blood flow. To interrogate transcriptional differences potentially contributing to CMD, we tested the hypothesis that comprehensive single-cell and spatial transcriptomic profiling of the coronary microcirculation and surrounding myocardium will identify new pathways to target in CMD. We utilized an innovative combination of single-cell RNA profiling and spatial transcriptomics to examine transcriptional differences and molecular signatures of CMD in T2D mice. Single-cell RNA profiling and spatial transcriptomics revealed an upregulation of genes linked to adipogenesis, fatty acid metabolism, and oxidative phosphorylation in T2D cell clusters and coronary microvascular-enriched regions. In ECs, VSMCs, cardiomyocyte clusters, fibroblasts, and macrophages, the upregulation of adipogenesis was directed by Angplt4 and Ephx2 , whereas Hmgcs2 and Acot2 were the key players in the upregulation of fatty acid metabolism, and Pdk4 and Ech1 were the drivers of oxidative phosphorylation upregulation. These intriguing data support the well-documented concept that cardiac metabolic inflexibility in T2D heart failure—characterized by reduced mitochondrial function, increased reliance on fatty acid oxidation, and impaired glucose utilization—contributes to oxidative stress and lipotoxicity. Our data unveiled novel and unique gene expression signatures of coronary microvessels in the presence and absence of diabetes.


  • Open Access

    Coronary cytoskeletal modulation of coronary blood flow in the presence and absence of type 2 diabetes: the role of cofilin

    by Patricia E. McCallinhart, Kathlyene R. Stone, Pamela A. Lucchesi, Aaron J. Trask

    Background: Coronary resistance microvessels (CRMs) from type 2 diabetic (T2DM) mice and pigs are less stiff compared to normal, a finding that is dictated by less stiff coronary vascular smooth muscle cells (VSMCs). Cofilin is an endogenous actin regulatory protein that depolymerizes filamentous (F)-actin, and portions of F-actin bound to cofilin are less stiff compared to their unbound F-actin counterparts. In this study, we hypothesized that altering the actin cytoskeleton modifies VSMC stiffness, which contributes to changes in coronary blood flow in normal and T2DM conditions.Methods and results: Utilizing phalloidin staining, we found that F-actin was significantly reduced in T2DM CRM VSMCs, and we showed cofilin expression was increased in T2DM by proteomics and Western blot analysis. Cofilin knockdown in both human and mouse coronary VSMCs using siRNA significantly increased F/G actin ratio. Cofilin knockdown also caused a significant increase in elastic modulus by atomic force microscopy of coronary VSMCs. Treatment with Latrunculin B, an actin disruptor, significantly decreased VSMC elastic modulus. Acute Latrunculin B infusion into the coronary circulation of ex vivo isolated Langendorff mouse hearts increased peak coronary blood flow.Conclusion: Together, we demonstrated that the CRM VSMC actin cytoskeleton is altered in T2DM to favor less stiff cells, and pharmacological manipulation of the actin cytoskeleton alters VSMC biomechanics. This study is also the first to demonstrate that coronary cellular modulation of mechanics can acutely modulate coronary blood flow.


  • Open Access

    Dissociation of pulse wave velocity and aortic wall stiffness in diabetic db/db mice: The influence of blood pressure

    by Patricia E. McCallinhart, Yong Ung Lee, Avione Lee, Mircea Anghelescu, Jeffrey R. Tonniges, Ed Calomeni, Gunjan Agarwal, Joy Lincoln, Aaron J. Trask

    Introduction: Vascular stiffness is a predictor of cardiovascular disease and pulse wave velocity (PWV) is the current standard for measuring in vivo vascular stiffness. Mean arterial pressure is the largest confounding variable to PWV; therefore, in this study we aimed to test the hypothesis that increased aortic PWV in type 2 diabetic mice is driven by increased blood pressure rather than vascular biomechanics.Methods and Results: Using a combination of in vivo PWV and ex vivo pressure myography, our data demonstrate no difference in ex vivo passive mechanics, including outer diameter, inner diameter, compliance (Db/db: 0.0094 ± 0.0018 mm2/mmHg vs. db/db: 0.0080 ± 0.0008 mm2/mmHg, p > 0.05 at 100 mmHg), and incremental modulus (Db/db: 801.52 ± 135.87 kPa vs. db/db: 838.12 ± 44.90 kPa, p > 0.05 at 100 mmHg), in normal versus diabetic 16 week old mice. We further report no difference in basal or active aorta biomechanics in normal versus diabetic 16 week old mice. Finally, we show here that the increase in diabetic in vivo aortic pulse wave velocity at baseline was completely abolished when measured at equivalent pharmacologically-modulated blood pressures, indicating that the elevated PWV was attributed to the concomitant increase in blood pressure at baseline, and therefore “stiffness.”Conclusions: Together, these animal model data suggest an intimate regulation of blood pressure during collection of pulse wave velocity when determining in vivo vascular stiffness. These data further indicate caution should be exerted when interpreting elevated PWV as the pure marker of vascular stiffness.


  • Hypertension Section Editors Series: Early Career Introduction and Update

    by Aaron J. Trask, Natalie A. Bello, Daniela Carnevale, Amy C. Arnold, Stephanie W. Watts

  • Open Access

    Invasive or More Direct Measurements Can Provide an Objective Early-Stopping Ceiling for Training Deep Neural Networks on Non-invasive or Less-Direct Biomedical Data

    by Christopher W. Bartlett, Jamie Bossenbroek, Yukie Ueyama, Patricia McCallinhart, Olivia A. Peters, Donna A. Santillan, Mark K. Santillan, Aaron J. Trask, William C. Ray

    Early stopping is an extremely common tool to minimize overfitting, which would otherwise be a cause of poor generalization of the model to novel data. However, early stopping is a heuristic that, while effective, primarily relies on ad hoc parameters and metrics. Optimizing when to stop remains a challenge. In this paper, we suggest that for some biomedical applications, a natural dichotomy of invasive/non-invasive measurements, or more generally proximal vs distal measurements of a biological system can be exploited to provide objective advice on early stopping. We discuss the conditions where invasive measurements of a biological process should provide better predictions than non-invasive measurements, or at best offer parity. Hence, if data from an invasive measurement are available locally, or from the literature, that information can be leveraged to know with high certainty whether a model of non-invasive data is overfitted. We present paired invasive/non-invasive cardiac and coronary artery measurements from two mouse strains, one of which spontaneously develops type 2 diabetes, posed as a classification problem. Examination of the various stopping rules shows that generalization is reduced with more training epochs and commonly applied stopping rules give widely different generalization error estimates. The use of an empirically derived training ceiling is demonstrated to be helpful as added information to leverage early stopping in order to reduce overfitting.


  • Open Access

    Improvement of automated analysis of coronary Doppler echocardiograms

    by Jamie Bossenbroek, Yukie Ueyama, Patricia E. McCallinhart, Christopher W. Bartlett, William C. Ray, Aaron J. Trask

    Coronary artery disease is the leading cause of heart disease, and while it can be assessed through transthoracic Doppler echocardiography (TTDE) by observing changes in coronary flow, manual analysis of TTDE is time consuming and subject to bias. In a previous study, a program was created to automatically analyze coronary flow patterns by parsing Doppler videos into a single continuous image, binarizing and separating the image into cardiac cycles, and extracting data values from each of these cycles. The program significantly reduced variability and time to complete TTDE analysis, but some obstacles such as interfering noise and varying video sizes left room to increase the program’s accuracy. The goal of this current study was to refine the existing automation algorithm and heuristics by (1) moving the program to a Python environment, (2) increasing the program’s ability to handle challenging cases and video variations, and (3) removing unrepresentative cardiac cycles from the final data set. With this improved analysis, examiners can use the automatic program to easily and accurately identify the early signs of serious heart diseases.